U.S. Logistics Stock News

Earlier this month, Cookeville Regional Medical Center and Encompass Health announced plans to build a freestanding, 40-bed inpatient rehabilitation hospital on Cookeville Regional’s campus in Tennessee, expanding services for patients recovering from strokes, neurological conditions, and complex injuries and integrating advanced therapy facilities and technologies. The alliance not only deepens Encompass Health’s presence in Tennessee but also converts and scales an existing 20-bed unit...

If you are wondering whether lululemon athletica's current share price reflects its true worth, this article walks through the numbers behind the stock so you can judge the value story for yourself. The stock last closed at US$138.16, with returns of a 15.5% decline over 7 days, a 5.3% decline over 30 days, a 34.5% decline year to date and a 49.0% decline over the past year, which naturally raises questions about how the market now views its growth prospects and risk. Recent headlines have...

Tradr has launched the 2X Short Lumentum ETF, a leveraged product designed to give traders amplified inverse exposure to Lumentum Holdings. The ETF focuses specifically on NasdaqGS:LITE, underscoring the company's role in AI focused optics and data center infrastructure. Lumentum Holdings, listed as NasdaqGS:LITE, currently sits at a share price of $858.32, with recent returns that are drawing attention. The stock is up 22.1% over the past 30 days and 122.3% year to date, while the very...

What Figure Technology Solutions stock’s recent moves tell you Figure Technology Solutions (FIGR) has been catching attention after a mixed run, with a 3.2% decline in the last day, a 6.7% drop over the past week, and an 8.3% gain over the month. See our latest analysis for Figure Technology Solutions. At a share price of $33.27, Figure Technology Solutions has a 30 day share price return of 8.3%. However, the 90 day share price return of a 45.0% decline points to fading momentum after...

Cognex Corporation recently launched the In-Sight 6900 Vision Controller, a modular, NVIDIA Jetson-powered edge AI system that lets manufacturers tailor cameras, optics, and lighting for demanding inspection tasks without external PCs or complex architectures. A particularly interesting aspect is its few-sample, transformer-based classification and robust segmentation, which aims to handle highly variable defects and dynamic production conditions while integrating tightly with Cognex’s...

Graco (NYSE:GGG) is marking its 100th anniversary with a global land art installation created in collaboration with artist Saype. The project uses Graco equipment to produce large scale, temporary artworks across multiple international locations. The anniversary initiative underscores Graco's global reach and the use of its technology in a high profile cultural setting. Graco, trading at $79.57, is using its centennial year to spotlight the brand in a way that goes beyond typical product or...

FS Bancorp (FXLG) prints steady Q1 2026 numbers FS Bancorp (FXLG) has opened 2026 with Q1 results that show total revenue of US$13.31 million and basic EPS of US$1.35, setting the tone against a backdrop of rising trailing twelve month earnings. The company has seen revenue move from US$11.68 million in Q1 2025 to US$13.31 million in Q1 2026, while basic EPS stepped from US$1.12 to US$1.35 over the same period, as trailing EPS reached US$5.20 on net income of US$21.46 million across the last...

Despite announcing strong earnings, CBRE Group, Inc.'s ( NYSE:CBRE ) stock was sluggish. Our analysis uncovered some...

Earlier this month, Vishay Intertechnology introduced 16 FRED Pt ultrafast rectifiers in its new low‑profile DFN6546A package with wettable flanks, targeting high‑efficiency commercial, industrial, and AEC‑Q101 automotive applications across temperature ranges from -55 °C to +175 °C. By combining a thinner footprint, higher current ratings than comparable packages, and features that enable automated optical inspection, these rectifiers are designed to save PCB space, improve power...

Tractor Supply (NasdaqGS:TSCO) has partnered with ITG and adopted Storyteq technology to automate and scale its marketing workflows. The company reports a 32% reduction in email marketing costs, with content production becoming more efficient without adding budget or headcount. This operational shift supports Tractor Supply's customer engagement efforts as it expands its footprint and marketing reach. Tractor Supply, trading at $34.77, has seen pressure on its share price, with a 23.2%...

In late April 2026, Centene Corporation reported first-quarter revenue of US$49.94 billion and net income of US$1.54 billion, with both basic and diluted EPS from continuing operations rising year on year. Alongside these results, Centene raised its 2026 earnings guidance, highlighting stronger-than-expected margins in its Medicaid and Medicare businesses while working to reprice its challenged Marketplace segment. We’ll now examine how Centene’s upgraded 2026 earnings outlook, driven by...

Why Ryan Specialty Holdings (RYAN) Is Back on Investors’ Radar Ryan Specialty Holdings (RYAN) is back in focus as it prepares to report earnings this Thursday after the close, following a quarter where revenue and EPS missed expectations despite 13.2% year-on-year revenue growth. The upcoming report comes after analysts turned more cautious over the past month and trimmed revenue estimates, while the company has been rolling out AI tools aimed at cutting costs and sharpening risk assessment...

Last week, you might have seen that Armstrong World Industries, Inc. ( NYSE:AWI ) released its first-quarter result to...

Etsy (ETSY) has just opened its 2026 reporting year with Q4 2025 numbers that show total revenue of US$881.6 million and basic EPS of US$1.13, setting the tone for how investors will read the upcoming Q1 2026 release. Over recent quarters the company has seen revenue move from US$662.4 million in Q3 2024 to US$678.0 million in Q3 2025 and from US$852.2 million in Q4 2024 to US$881.6 million in Q4 2025, while basic EPS over those same fourth quarters shifted from US$1.17 to US$1.13 as...

In April 2026, AppLovin disclosed a shareholder proposal from the Connecticut Retirement Plans and Trust Funds on class-by-class vote reporting and proposed amending its certificate of incorporation to add Delaware-permitted officer exculpation, both to be decided at the June 3, 2026 annual meeting. These governance moves, alongside ongoing leadership transitions and legal restructuring, highlight how AppLovin is reshaping its oversight framework just as investors focus on upcoming earnings...

F5, Inc. recently reported Q2 FY2026 results with revenue of US$811.7 million and modestly higher net income, while also appointing Veeam CEO Anand Eswaran to its board and key committees. The company raised its full-year 2026 revenue growth guidance to 7%–8% and highlighted growing demand for its AI-focused security and multicloud offerings as key drivers. With F5 now guiding higher full-year revenue growth, we’ll examine how this updated outlook reshapes the company’s existing investment...

EMCOR Group (EME) heads into its Q1 2026 reporting cycle coming off a strong finish to 2025, with Q4 revenue of US$4.5b and basic EPS of US$9.72, alongside trailing twelve month revenue of US$17.0b and EPS of US$28.30. Over the past six quarters, the company has seen revenue move from US$3.7b in Q3 2024 to US$4.5b in Q4 2025, while basic EPS over that span has ranged between US$5.27 and US$9.72, supported by a trailing net profit margin of 7.5% compared with 6.9% a year earlier. That...

In recent days, attention on CRISPR Therapeutics has intensified ahead of its March-quarter earnings report, as analysts expect higher revenue and earnings alongside evolving estimates. Investor focus is also being shaped by rising sales of Casgevy, the gene-editing therapy co-developed with Vertex Pharmaceuticals, which is showing sequential launch momentum. We’ll now examine how expectations for stronger quarterly results and early Casgevy uptake could influence CRISPR Therapeutics’...

Why geopolitics suddenly matter more for Frontline (NYSE:FRO) Shipping routes have been disrupted by the Iran war and wider transit uncertainty, pushing tanker rates higher and drawing fresh attention to tanker owners such as Frontline (NYSE:FRO) as investors reassess shipping exposure. See our latest analysis for Frontline. Frontline's share price has moved to US$36.28, with a 30 day share price return of 8.66% and a 90 day share price return of 28.15%. Its 1 year total shareholder return of...

Trip.com Group recently reported that multi-city and multi-destination travel across Asia-Pacific grew 35% year-on-year over the Labour Day period, while also filing its 2025 Form 20-F with the SEC and making its audited financials available to investors. The company’s inclusive “Trip for Everyone” app, which supports visually impaired and elderly travelers, received the prestigious iF DESIGN AWARD 2026, underscoring how accessibility-focused innovation is becoming a core differentiator in...

If you are wondering whether Photronics at US$47.77 is starting to look expensive or still offers value, the recent share performance gives you a useful starting point. The stock has seen a 1 year return of 159.3%, with year to date gains of 43.0% and a 30 day return of 18.2%, although the last 7 days showed a 5.4% decline. Recent coverage has focused on Photronics as a semiconductor player that some investors watch closely for exposure to chip manufacturing trends and potential shifts in...

At its June 10, 2026 Annual Meeting, Clear Secure, Inc. previously proposed amending its Certificate of Incorporation to remove certain supermajority vote requirements and to clarify its officer exculpation provision, while also reporting quarterly revenue growth that exceeded analyst expectations. Together, these governance changes and stronger-than-expected financial results highlight how Clear Secure is adjusting its corporate structure while capitalizing on momentum in its identity...

Coastal Financial (CCB) has opened Q1 2026 earnings season with trailing 12 month revenue of US$349.0 million and basic EPS of US$3.12, setting the backdrop for its latest quarterly update. Over recent periods, the bank has seen total revenue move from US$303.6 million to US$349.0 million and basic EPS shift from US$3.35 to US$3.12 on a trailing 12 month basis, which frames how the income line is translating into per share results. With trailing net profit margin easing from 14.9% to 13.5%,...

Viking Therapeutics has reported Q1 2026 results, with a net loss of US$158.33 million and basic and diluted loss per share of US$1.37, while also completing patient enrollment in its Phase 3 VANQUISH-2 trial of obesity drug candidate VK2735. This combination of heavier quarterly losses and a pivotal trial milestone highlights the tension between mounting development costs and the potential long-term importance of VK2735 in Viking’s pipeline. Next, we’ll examine how completing enrollment in...